昆山杜克大学汤胜蓝教授团队“建立有效且可持续的中国国家免疫规划:问题及挑战”10月11日于《柳叶刀–公共卫生》在线发表。文章系统回顾了国家免疫规划取得的重大成就、当前面临的挑战,建言更有效、更可持续的国家免疫规划未来发展策略。
Closing the immunization gap: Overcoming barriers for new vaccine introduction in Southeast and South Asia
This review, conducted by Innovation Lab for Vaccine Delivery Research (VaxLab) from Duke Kunshan University, was published in Vaccine. The study systematically compares the status of new vaccine introduction within national immunization programs across 13 countries in Southeast and South Asia, with a particular focus on differences associated with Gavi funding eligibility. The findings show that countries eligible for Gavi’s middle-income country (MIC) support approach lag behind in introducing key vaccines such as pneumococcal conjugate vaccine (PCV), human papillomavirus (HPV) vaccine, and rotavirus vaccine. Major barriers include underdeveloped evidence-based decision-making processes, limited domestic financing, high vaccine prices, and gaps in immunization system readiness. This article highlights the need to strengthen governance and sustainable financing mechanisms, optimize resource use, and leverage targeted technical support from global partners to accelerate equitable access to life-saving vaccines and advance the Immunization Agenda 2030.